Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD33 Delineates Two Functionally Distinct NK Cell Populations Divergent in Cytokine Production and Antibody-Mediated Cellular Cytotoxicity.
Hejazi M, Zhang C, Bennstein SB, Balz V, Reusing SB, Quadflieg M, Hoerster K, Heinrichs S, Hanenberg H, Oberbeck S, Nitsche M, Cramer S, Pfeifer R, Oberoi P, Rühl H, Oldenburg J, Brossart P, Horn PA, Babor F, Wels WS, Fischer JC, Möker N, Uhrberg M. Hejazi M, et al. Among authors: babor f. Front Immunol. 2022 Jan 4;12:798087. doi: 10.3389/fimmu.2021.798087. eCollection 2021. Front Immunol. 2022. PMID: 35058934 Free PMC article.
HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation.
Reusing SB, Manser AR, Groeneveld-Krentz S, Rebmann V, Horn PA, Meisel R, Karawajew L, Borkhardt A, Uhrberg M, Babor F. Reusing SB, et al. Among authors: babor f. Bone Marrow Transplant. 2021 Jul;56(7):1723-1727. doi: 10.1038/s41409-021-01231-y. Epub 2021 Mar 3. Bone Marrow Transplant. 2021. PMID: 33658648 Free PMC article. No abstract available.
Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL.
Reusing SB, Vallera DA, Manser AR, Watrin T, Bhatia S, Felices M, Miller JS, Uhrberg M, Babor F. Reusing SB, et al. Among authors: babor f. Cancer Immunol Immunother. 2021 Dec;70(12):3709. doi: 10.1007/s00262-021-03040-0. Cancer Immunol Immunother. 2021. PMID: 34491408 Free PMC article. No abstract available.
Selective downregulation of HLA-C and HLA-E in childhood acute lymphoblastic leukaemia.
Reusing SB, Manser AR, Enczmann J, Mulder A, Claas FH, Carrington M, Fischer JC, Borkhardt A, Babor F, Uhrberg M. Reusing SB, et al. Among authors: babor f. Br J Haematol. 2016 Aug;174(3):477-80. doi: 10.1111/bjh.13777. Epub 2015 Nov 3. Br J Haematol. 2016. PMID: 26527563 Free PMC article. No abstract available.
Haploidentical stem cell transplantation in DOCK8 deficiency - Successful control of pre-existing severe viremia with a TCRaß/CD19-depleted graft and antiviral treatment.
Ghosh S, Schuster FR, Adams O, Babor F, Borkhardt A, Comoli P, Handgretinger R, Lang P, Laws HJ, Siepermann M, Meisel R. Ghosh S, et al. Among authors: babor f. Clin Immunol. 2014 May-Jun;152(1-2):111-4. doi: 10.1016/j.clim.2014.03.006. Epub 2014 Mar 22. Clin Immunol. 2014. PMID: 24667686 No abstract available.
Clearance of Treatment Refractory Adenoviremia via Adenovirus-specific Donor T-Cell Transfer During Aplasia After αβTCR-CD19-Depleted Stem Cell Transplantation.
Gössling KL, Fouz H, Kyrillopoulou O, Aubin M, Maecker-Kolhoff B, Adams O, Borkhardt A, Babor F, Schuster FR, Siepermann M, Schumm M, Lang P, Eiz-Vesper B, Meisel R. Gössling KL, et al. Among authors: babor f. Clin Infect Dis. 2019 Apr 8;68(8):1406-1409. doi: 10.1093/cid/ciy820. Clin Infect Dis. 2019. PMID: 30357314
27 results